Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19

BACKGROUND: Acute lung injury (ALI) is a common complication of sepsis with poor effective interventions. Huashibaidu formula (HSBD) showed good therapeutic effects in treating coronavirus disease 2019 (COVID-19) patients. PURPOSE: This study was designed to investigate the therapeutic potential and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangbo, Guo, Feifei, Zhang, Yi, Xu, He, Liu, Yuling, Lin, Longfei, Li, Hui, Yang, Hongjun, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674563/
https://www.ncbi.nlm.nih.gov/pubmed/36610129
http://dx.doi.org/10.1016/j.phymed.2022.154549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674563/
https://www.ncbi.nlm.nih.gov/pubmed/36610129
http://dx.doi.org/10.1016/j.phymed.2022.154549

Ejemplares similares